Lipella Pharmaceuticals Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,888 | -2,634 | -1,307 | -5,016 | -3,575 |
| Depreciation Amortization | 2 | 1 | 1 | 3 | 2 |
| Accounts receivable | 85 | 43 | -1 | -52 | 1 |
| Accounts payable and accrued liabilities | 75 | 220 | 4 | 250 | 321 |
| Other Working Capital | 101 | -227 | -120 | 113 | -257 |
| Other Operating Activity | -159 | -263 | -3 | 752 | 546 |
| Operating Cash Flow | $-3,785 | $-2,859 | $-1,426 | $-3,951 | $-2,960 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,456 | 3,456 | 3,466 | N/A | 1,020 |
| Other Financing Activity | 0 | 0 | 0 | 2,842 | 0 |
| Financing Cash Flow | $3,456 | $3,456 | $3,466 | $2,842 | $1,020 |
| Beginning Cash Position | 2,185 | 2,185 | 2,185 | 3,294 | 3,294 |
| End Cash Position | 1,856 | 2,782 | 4,225 | 2,185 | 1,354 |
| Net Cash Flow | $-329 | $597 | $2,040 | $-1,109 | $-1,940 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,785 | -2,859 | -1,426 | -3,951 | -2,960 |
| Free Cash Flow | -3,785 | -2,859 | -1,426 | -3,951 | -2,960 |